DY268 is a farnesoid X receptor (FXR) antagonist (IC50=7.5 nM). It inhibits FXR transactivation in a cell-based assay with an IC50 value of 468 nM. DY268 can be used in the study of drug-induced liver injury (DILI)[1][2].
Molecular Weight:
560.66
Purity:
99.32
CAS Number:
[1609564-75-1]
Formula:
C30H32N4O5S
Target:
FXR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted